Search research articles
Contact Us
Filters
Showing results (21-30 of 85) with videos related to
Page
of 9
Sort By:
Clinical Science (London, England : 1979)
|
June 5, 2024
Targeting the endothelium by combining endothelin-1 antagonism and SGLT-2 inhibition: better together?
Phil Ambery, Peter J Greasley, Robert I Menzies, et al.
Drug Discovery Today
|
November 7, 2012
Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case
Thierry Kogej, Niklas Blomberg, Peter J Greasley, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Novel thioamide derivatives as neutral CB1 receptor antagonists
Jonas Boström, Roine I Olsson, Joakim Tholander, et al.
FEBS Letters
|
December 29, 2004
Identification and characterisation of a novel splice variant of the human CB1 receptor
Erik Ryberg, Huy Khang Vu, Niklas Larsson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
April 21, 2011
N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis
Ayelet Cohen-Yeshurun, Victoria Trembovler, Alexander Alexandrovich, et al.
BMC Nephrology
|
August 31, 2025
Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression
Dianne Acoba, Anna Levin, Anna Witasp, et al.
Kidney International Reports
|
October 26, 2020
Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes
Claudia S Cabrera, Alison S Lee, Marita Olsson, et al.
Diabetes, Obesity & Metabolism
|
August 14, 2019
Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes
Claire C J Dekkers, C David Sjöström, Peter J Greasley, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
May 13, 2017
A common NHE3 single-nucleotide polymorphism has normal function and sensitivity to regulatory ligands
Jianyi Yin, Chung-Ming Tse, Boyoung Cha, et al.
Diabetes, Obesity & Metabolism
|
May 21, 2025
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease
Victor Wasehuus, J David Smeijer, Phil Ambery, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 85) with videos related to
Sort By:
Page
of 9
Clinical Science (London, England : 1979)
|
June 5, 2024
Targeting the endothelium by combining endothelin-1 antagonism and SGLT-2 inhibition: better together?
Phil Ambery, Peter J Greasley, Robert I Menzies, et al.
Drug Discovery Today
|
November 7, 2012
Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case
Thierry Kogej, Niklas Blomberg, Peter J Greasley, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Novel thioamide derivatives as neutral CB1 receptor antagonists
Jonas Boström, Roine I Olsson, Joakim Tholander, et al.
FEBS Letters
|
December 29, 2004
Identification and characterisation of a novel splice variant of the human CB1 receptor
Erik Ryberg, Huy Khang Vu, Niklas Larsson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
April 21, 2011
N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis
Ayelet Cohen-Yeshurun, Victoria Trembovler, Alexander Alexandrovich, et al.
BMC Nephrology
|
August 31, 2025
Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression
Dianne Acoba, Anna Levin, Anna Witasp, et al.
Kidney International Reports
|
October 26, 2020
Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes
Claudia S Cabrera, Alison S Lee, Marita Olsson, et al.
Diabetes, Obesity & Metabolism
|
August 14, 2019
Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes
Claire C J Dekkers, C David Sjöström, Peter J Greasley, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
May 13, 2017
A common NHE3 single-nucleotide polymorphism has normal function and sensitivity to regulatory ligands
Jianyi Yin, Chung-Ming Tse, Boyoung Cha, et al.
Diabetes, Obesity & Metabolism
|
May 21, 2025
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease
Victor Wasehuus, J David Smeijer, Phil Ambery, et al.
Page
of 9